my account log out | |
Anti-TACSTD2 (hRS7)-CL2E-SN-38 ADC |
Create: 04/27/2019 |
Expired Date: | never |
Category: | Drugs&Pharmaceutical [Health&Medical&Pharmaceutical] |
Message: | This ADC product is comprised of an anti-TACSTD2 monoclonal antibody (hRS7) conjugated via a CL2E linker to SN-38 . The SN-38 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, SN-38 binds to DNA, causes DNA damage.https://www.creative-biolabs.com/adc/target-tacstd2-93.htm |
City: | Shirley[US] |
Location: | |
Feb 01 2023 | VBS++ (with Ca and Mg) Buffer | 215 | |
Feb 01 2023 | GVBE Buffer | 214 | |
Feb 01 2023 | GVB++ (with Ca and Mg) Buffer | 221 | |
Feb 01 2023 | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | 209 | |
Aug 30 2019 | Anti-HSV-2 gH Antibody | 393 | |
Aug 30 2019 | Anti-L. major LPG Antibody | 478 | |
Aug 30 2019 | Anti-DENV-1 Antibody | 386 | |
Aug 30 2019 | Anti-BPV-1 L1 Antibody | 403 | |
Aug 30 2019 | Anti-H3N2 HA Antibody | 387 | |
Aug 30 2019 | Anti-EIAV env Antibody | 412 |
Copyright © toextrade Inc. All rights reserved. Contact us |